SOAT1 and ovarian cancer: Current studies have suggested that the enhancement of JAK/STAT pathway activity can promote the proliferation, growth, invasion and metastasis of ovarian cancer cells, inhibit cell apoptosis, and progress towards cisplatin resistance [22].